Deal Structuring Best Practices: Navigating Complex Transactions
bIAnk AI Research · November 2025 · 10 min
Modern M&A requires sophisticated structuring approaches. From earnouts to CVRs, understanding the toolkit is essential for closing complex deals.
The complexity of modern M&A transactions demands sophisticated structuring approaches that balance risk allocation between buyers and sellers while ensuring deal certainty. Understanding the full toolkit of structuring options is essential for successful transaction execution.
Earnout arrangements have become increasingly prevalent, particularly in technology and life sciences transactions where future performance is uncertain. Well-designed earnouts can bridge valuation gaps while aligning incentives between parties. Key considerations include metric selection, measurement periods, and anti-sandbagging provisions.
Contingent value rights (CVRs) represent a specialized form of earnout commonly used in pharmaceutical transactions. CVRs typically tied to regulatory milestones or commercial thresholds allow buyers to share risk while sellers retain upside from pipeline success.
Representations and warranties insurance (R&W) has become standard in PE transactions and increasingly common in strategic deals. R&W policies allow sellers to achieve cleaner exits while providing buyers with meaningful protection. Market practice has evolved toward buyer-side policies with sellers providing a modest retention.
Tax structuring remains critical to transaction value optimization. Asset vs. stock transactions, Section 338(h)(10) elections, and jurisdictional considerations can significantly impact after-tax proceeds. Early engagement of tax advisors is essential.
Regulatory considerations increasingly shape deal structure. Antitrust risk allocation, regulatory conditions precedent, and break fee structures require careful negotiation. In sensitive sectors, reverse break fees have become larger to compensate sellers for regulatory uncertainty.
Financing conditions have evolved in the current environment. Buyers increasingly seek SunGard-style conditionality limiting financing outs, while lenders push for more protective covenants. Understanding the interplay between acquisition agreements and financing commitments is crucial.
Key takeaways
- Earnouts bridge valuation gaps with proper metric selection and measurement
- R&W insurance standard in PE, increasingly common in strategic deals
- Tax structuring critical: asset vs. stock, 338(h)(10) elections matter
- Regulatory risk allocation and financing conditions key to deal certainty